TrialCancer medicine2018

Determination of a radotinib dosage regimen based on dose-response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia.

Hayeon Noh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.